All News

The 5 leading advocacy groups said the safety of people with obesity is at risk and called on the FDA to change clinical trial inclusion requirements and expedite labeling changes.

Arun Jesudian, MD, details key findings from a study he recently presented at The Liver Meeting 2023.

Your daily dose of the clinical news you may have missed.

Review the ACC/AHA guidelines on prevention of ASCVD through lifestyle and risk factor assessment and management in our at-a-glance slide show.

Physiatrist Saloni Sharma, MD, stresses the essential role of coordinated, multidisciplinary care for a person with neuropathic pain—and any person with limited function.

Early CT screening led to a 20-year lung cancer survival rate of 81% in the International Early Lung Cancer Action Program. Details, here.

Cardiovascular mortality has been increasing among middle-aged US adult since 2011; a new study looked at changes in CV risk factors by income level over the past 20 years.

Dupilumab reduced COPD exacerbations by more than one-third in the phase 3 NOTUS trial, matching outcomes from the earlier BOREAS study this year.

A 62-year-old woman reports several days of abdominal bloating and vomiting that changed 2 hours ago into severe generalized pain. Review the bedside ultrasound, here.

Chiadi Ndumele, MD, PhD, MHS, offers 3 thoughts for primary care on incorporating CKM syndrome screening into daily clinical practice.

An obesity specialist discusses the importance of using a weight-first approach when educating patients about obesity's role in the development and worsening of hypertension.

According to physical medicine and rehabilitation physician Saloni Sharma, MD, treatment for neuropathic pain draws on PM&R's many strengths.

Investigators found that the gender life expectancy gap increased 0.23 years from 2010 to 2019 and 0.70 years from 2019 to 2021.

Your daily dose of the clinical news you may have missed.

The novel oral anticoagulant is one in a class of agents for prevention of AF-related stroke that shows promise to reduce bleeding risk.

Absolute risk assessment for CVD remains the corner-stone of clinical primary prevention efforts. The new AHA prediction models expand that foundation.

Your daily dose of the clinical news you may have missed.

Patients with obesity and hypertension need to be aggressively treated in order to decrease their risk of cardiovascular complications, says Dr Jonathan Parker, President of the Alabama Obesity Society.